跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALIPERIDONE-TEVA paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
PALIPERIDONE-TEVA paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe
Approved
STANDARD
PALIPERIDONE-TEVA paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
3595b3fb43fda804
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
3595b3fb43fda804
Product Name
PALIPERIDONE-TEVA paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe
Artg Id
404384
Artg Name
PALIPERIDONE-TEVA paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2024-06-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
3595b3fb43fda804
Type
Standard
Back to TGA Approvals